SCHEMBL8897762

SCHEMBL8897762

CC(Cl)c1cccc(C(C)Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 4/20 0.44
PGK2 P07205 4/20 0.44
TSHR P16473 1/20 0.41
HDAC4 P56524 3/20 0.37
HDAC8 Q9BY41 3/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HDAC2 Q92769 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MDM4 O15151 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
TYR P14679 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
CA5A P35218 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8750604 0.85 ACHE (0.50) MAPTSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL8094299 0.85 PNMT (0.45) TSHRALDH1A1HPGDADRB1
SCHEMBL30549338 0.85 PNMT (0.45) TSHRALDH1A1HPGDADRB1
SCHEMBL22926647 0.84 HDAC4 (0.53) PGK1PGK2TSHRHDAC4HDAC8
SCHEMBL38663914 0.83 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1CYP3A4MEN1KMT2A
SCHEMBL931961 0.83 ACHE (0.44) HDAC4SMN1; SMN2
SCHEMBL28744749 0.83 ADRB1 (0.57) TSHRKDM4EALDH1A1CA2CYP3A4
SCHEMBL212526 0.83 ACHE (0.44) HDAC4SMN1; SMN2
SCHEMBL30058998 0.83 ACHE (0.44) HDAC4SMN1; SMN2
SCHEMBL5843001 0.83 PGK1 (0.38) PGK1PGK2TSHRHDAC4HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150001178-A1 MONOMER FOR HARDMASK COMPOSITION AND HARDMASK COMPOSITION INCLUDING THE MONOMER AND METHOD OF FORMING PATTERNS USING THE HARDMASK COMPOSITION CHEIL INDUSTRIES, INC. (KR) 2015-01-01 US disclosed
EP-0531715-B1 Process for producing alcohols and ketones SUMITOMO CHEMICAL CO (JP) 1997-11-05 EP disclosed
US-5426237-A Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde SUMITOMO CHEMICAL CO., LTD. (JP) 1995-06-20 US disclosed
EP-0531715-A1 Process for producing alcohols and ketones SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-03-17 EP disclosed
EP-0032062-B2 HIGH-MOLECULAR-WEIGHT NOVOLAK SUBSTITUTED PHENOLIC RESINS AND THEIR PREPARATION MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-10-16 EP disclosed
EP-0071833-B1 PROCESS FOR PRODUCING 4-BENZOYLPYRAZOLES ISHIHARA SANGYO KAISHA, LTD. (JP) 1987-02-04 EP disclosed
US-4560814-A Process for alkylating halogenated and trifluoromethylated benzene compounds RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1985-12-24 US disclosed
US-4415739-A Process for producing 4-benzoylpyrazoles ISHIHARA SANGYO KAISHA LTD. (JP) 1983-11-15 US disclosed
EP-0071833-A1 Process for producing 4-benzoylpyrazoles ISHIHARA SANGYO KAISHA, LTD. (JP) 1983-02-16 EP disclosed
US-4345054-A High-molecular-weight novolak types substituted phenolic resins and process for preparation thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1982-08-17 US disclosed
US-3968138-A HERBICIDE UNITED STATES BORAX & CHEMICAL CORPORATION (US) 1976-07-06 US disclosed
US-3939084-A Functional fluid compositions containing substituted pyrimidines MONSANTO COMPANY (US) 1976-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150001178-A1 MONOMER FOR HARDMASK COMPOSITION AND HARDMASK COMPOSITION INCLUDING THE MONOMER AND METHOD OF FORMING PATTERNS USING THE HARDMASK COMPOSITION ARCN1, DDRGK1, ACTN1 PGK1 241/4885PGK2 465/4885TSHR 4713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.